Title: A Double-Blind Trial Comparing the Efficacy, Tolerability and Safety of Monotherapy Topiramate versus Phenytoin in Subjects with Seizures Indicative of New Onset Epilepsy
Principal Investigator: Cormac O’Donovan, M.D.
Multi-site, randomized, double-blind, Topamax vs. Dilantin for new onset epilepsy with 48 open-label (Topamax) extension
Inclusion Criteria: Epilepsy patient having had at least 2 but no more than 20 seizures/age12 to 65/patient appropriate for rapid initiation of Topamax or Dilantin
Epilepsy Active and Enrolling
Contact: Nancy Buchheimer
336-716-3961
nbuchhe@wfubmc.edu
Sponsor: Johnson and Johnson – Active and Enrolling